vs

Side-by-side financial comparison of FIVE STAR BANCORP (FSBC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $45.1M, roughly 1.8× FIVE STAR BANCORP). FIVE STAR BANCORP runs the higher net margin — 41.3% vs -38.1%, a 79.3% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 21.3%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FSBC vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.8× larger
PRCT
$83.1M
$45.1M
FSBC
Higher net margin
FSBC
FSBC
79.3% more per $
FSBC
41.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
21.3%
FSBC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FSBC
FSBC
PRCT
PRCT
Revenue
$45.1M
$83.1M
Net Profit
$18.6M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
41.3%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
42.0%
-27.9%
EPS (diluted)
$0.87
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSBC
FSBC
PRCT
PRCT
Q1 26
$45.1M
$83.1M
Q4 25
$43.5M
$76.4M
Q3 25
$41.3M
$83.3M
Q2 25
$38.3M
$79.2M
Q1 25
$35.3M
$69.2M
Q4 24
$35.2M
$68.2M
Q3 24
$31.8M
$58.4M
Q2 24
$30.7M
$53.4M
Net Profit
FSBC
FSBC
PRCT
PRCT
Q1 26
$18.6M
$-31.6M
Q4 25
$17.6M
$-29.8M
Q3 25
$16.3M
$-21.4M
Q2 25
$14.5M
$-19.6M
Q1 25
$13.1M
$-24.7M
Q4 24
$13.3M
$-18.9M
Q3 24
$10.9M
$-21.0M
Q2 24
$10.8M
$-25.6M
Gross Margin
FSBC
FSBC
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
FSBC
FSBC
PRCT
PRCT
Q1 26
-4.1%
Q4 25
52.9%
-40.6%
Q3 25
53.8%
-27.8%
Q2 25
52.4%
-28.0%
Q1 25
52.0%
-39.7%
Q4 24
55.1%
-28.9%
Q3 24
48.0%
-38.4%
Q2 24
49.4%
-50.3%
Net Margin
FSBC
FSBC
PRCT
PRCT
Q1 26
41.3%
-38.1%
Q4 25
40.6%
-39.1%
Q3 25
39.6%
-25.7%
Q2 25
37.9%
-24.7%
Q1 25
37.1%
-35.8%
Q4 24
37.9%
-27.6%
Q3 24
34.4%
-35.9%
Q2 24
35.2%
-48.0%
EPS (diluted)
FSBC
FSBC
PRCT
PRCT
Q1 26
$0.87
$-0.56
Q4 25
$0.83
$-0.54
Q3 25
$0.77
$-0.38
Q2 25
$0.68
$-0.35
Q1 25
$0.62
$-0.45
Q4 24
$0.61
$-0.34
Q3 24
$0.52
$-0.40
Q2 24
$0.51
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSBC
FSBC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$644.4M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$458.5M
$347.7M
Total Assets
$5.0B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSBC
FSBC
PRCT
PRCT
Q1 26
$644.4M
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
FSBC
FSBC
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
FSBC
FSBC
PRCT
PRCT
Q1 26
$458.5M
$347.7M
Q4 25
$445.8M
$365.9M
Q3 25
$431.3M
$380.3M
Q2 25
$416.7M
$385.8M
Q1 25
$406.5M
$389.2M
Q4 24
$396.6M
$402.2M
Q3 24
$389.9M
$241.2M
Q2 24
$380.5M
$251.8M
Total Assets
FSBC
FSBC
PRCT
PRCT
Q1 26
$5.0B
$487.1M
Q4 25
$4.8B
$508.1M
Q3 25
$4.6B
$511.5M
Q2 25
$4.4B
$513.1M
Q1 25
$4.2B
$519.4M
Q4 24
$4.1B
$534.0M
Q3 24
$3.9B
$374.1M
Q2 24
$3.6B
$374.4M
Debt / Equity
FSBC
FSBC
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSBC
FSBC

Net Interest Income$43.5M96%
Noninterest Income$1.6M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons